CD34 and cervical carcinoma: The use of antibodies to CD34 and podoplanin as markers made it possible to clarify the features of the morphology and localization of lymphatic vessels, to compare their number with the number of CD34-positive vessels as well as to evaluate the clinical significance of the lymphatic vessels in early cervical cancer.